Mettler-Toledo International, Inc. $MTD Shares Purchased by Goldman Sachs Group Inc.

Key Points

• Goldman Sachs Group Inc. increased its stake in Mettler-Toledo International by 15.7% in the first quarter, owning 169,805 shares valued at approximately $200.5 million.
• Mettler-Toledo reported earnings of $10.09 EPS for the quarter, exceeding expectations, with a revenue of $983.22 million, reflecting a 3.9% year-over-year increase.
• Analysts have set a consensus price target of $1,311.11 for Mettler-Toledo, with various brokerages updating their ratings and price objectives recently.

Goldman Sachs Group Inc. boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 15.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 169,805 shares of the medical instruments supplier's stock after buying an additional 22,992 shares during the quarter. Goldman Sachs Group Inc. owned 0.82% of Mettler-Toledo International worth $200,524,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $41,000. Zions Bancorporation National Association UT acquired a new position in Mettler-Toledo International during the first quarter worth $43,000. Golden State Wealth Management LLC grew its holdings in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares during the last quarter. Menard Financial Group LLC acquired a new stake in Mettler-Toledo International in the fourth quarter valued at $67,000. Finally, Blue Trust Inc. increased its position in shares of Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,253.87 on Thursday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01. The company's 50 day simple moving average is $1,256.54 and its 200 day simple moving average is $1,186.62. The company has a market capitalization of $25.83 billion, a price-to-earnings ratio of 31.75, a PEG ratio of 3.86 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same period in the previous year, the company earned $9.65 EPS. Mettler-Toledo International's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently commented on MTD. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target on the stock. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research report on Thursday, August 21st. Finally, Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

Insider Activity at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares of the company's stock, valued at $368,154.70. This represents a 78.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is currently owned by insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.